Taisho Pharmaceutical Co., Ltd. [Head Office: Toshima-ku, Tokyo; President: Shigeru Uehara] (hereinafter referred to as "the Company") hereby announces that sales of "Claritin EX" (Class 2 OTC Drug) from the Company will end at the end of September 2026.

While the Company's sales of "Claritin EX" will cease, Bayer Yakuhin, Ltd., the brand's responsible entity, is currently considering future sales policies for "Claritin EX".

Details are expected to be announced by Bayer Yakuhin, Ltd. once they are finalized. We express our deepest gratitude to our customers and all stakeholders who have patronized us for many years.

"Claritin EX" List

Product Name / Packaging

Claritin EX / 7 tablets

Claritin EX / 14 tablets

Claritin EX / 28 tablets

Claritin EX / 56 tablets

◇ Brand Site

https://brand.taisho.co.jp/claritin/

◇ Inquiries about products from consumers

Customer Service Center TEL: 0120-721-800

FACT BOX

  • Source: PR TIMES
  • Category: 製品終了